Spirulina and Cardiovascular Diseases | La Espirulina y las Enfermedades Cardiovasculares


Several studies, some advanced and other preliminary Spirulina use in preventing cardiovascular diseases.

The results of these studies clearly show that Spirulina intake lowers blood pressure and the concentration of blood lipids, especially triglycerides and low-density lipoprotein (bad cholesterol), and indirectly modifies the values ​​of total cholesterol and lipoproteins high density (good cholesterol).

Other species intake antioxidants such as vitamin C, vitamin E, coenzyme Q10 and various types of flavonoids (natural substances contained in many plant species) substantially improves this action, as all of these compounds are involved in the arrest of oxidative processes responsible for the deterioration of the walls of veins and arteries, as well as in the production of nitric oxide in the body.


La Espirulina y las Enfermedades Cardiovasculares 

Existen varios estudios, algunos avanzados y otros preliminares sobre el uso de la Espirulina en la prevención de las enfermedades cardiovasculares.

Los resultados de todos estos estudios muestran claramente que la ingesta de Espirulina disminuye la presión arterial y la concentración de lípidos en la sangre, especialmente los triglicéridos y lipoproteínas de baja densidad (Colesterol Malo), e indirectamente modifica los valores de colesterol total y lipoproteínas de alta densidad (Colesterol bueno).

La ingesta de otras especies antioxidantes, como la vitamina C, vitamina E, coenzima Q10 y diversos tipos de flavonoides (sustancias naturales vegetales contenidas en gran cantidad de especies), mejora sustancialmente esta acción, ya que todos estos compuestos intervienen en la detención de los procesos oxidativos responsables del deterioro de las paredes de venas y arterias, como así también en la producción de óxido nítrico en el cuerpo.

Danilo Vega
Skype: celuservis
990279998

DXN Ganoderma and treatment of Diabetes

DXN Ganoderma and treatment of Diabetes
  In the Kinki Institute conducted a study of Ganoderma lucidum with elderly diabetic patients (in some cases, it was suppressing insulin treatment). In the first few months it was found that rates of glucose experienced small bumps.

During treatment, some of the most common symptoms of decreased treaties, appearing significant improvements in general. After a year, a high percentage of patients achieved normalization of glucose levels.

It is considered that Ganoderma lucidum acts similar to insulin, inhibiting the formation of glucose and facilitating their entry into cells. Furthermore, we have contrasted the action exerted by the Ganoderma lucidum in the immune system, also favors the condition of patients with Type I Diabetes Mellitus

Taking Ganoderma lucidum obtain the following results:

     Acts similar to insulin, glucose inhibits the synthesis and facilitates its entry into cells.
     Reduces levels of blood glucose.
     Reduce symptoms of diabetics.
     Improving the autoimmune response in case of Type I Diabetes Mellitus
     Prevents diabetes and prevent its complications or sequelae.
     Promotes efficient glucose metabolism in the liver.


Danilo Vega
danilovegam@gmail.com
Skype: celuservis
990279998